Matthew Faber

Company: Xencor

Job title: Principal Scientist

Seminars:

Preclinical Showcase of XmAb541 in Claudin 6-Targeted Bispecific Antibody Therapy 9:30 am

Showcasing Xencor’s XmAb541, a CLDN6 x CD3 bispecific antibody, designed to engage T cells and selectively kill claudin 6 expressing tumor cells while sparing normal tissuesRead more

day: Conference Day 1